Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.33
-0.34-6.00%
At close: -
$5.50
0.173.19%
After Hours: 4:10 PM EDT
Comments
Loading...
Bausch Health Companies Analyst Ratings and Price Targets | NYSE:BHC | Benzinga
Bausch Health Companies Inc has a consensus price target of $7.33 based on the ratings of 8 analysts. The high is $10 issued by RBC Capital on January 30, 2025. The low is $3 issued by Piper Sandler on August 2, 2024. The 3 most-recent analyst ratings were released by Jefferies, RBC Capital, and RBC Capital on February 6, 2025, January 30, 2025, and November 1, 2024, respectively. With an average price target of $9.67 between Jefferies, RBC Capital, and RBC Capital, there's an implied 75.76% upside for Bausch Health Companies Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Jefferies
RBC Capital
Piper Sandler
Truist Securities
Raymond James
1calculated from analyst ratings
Analyst Ratings for Bausch Health Companies
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/06/2025 | Buy Now | 45.45% | Jefferies | David Steinberg67% | $12 → $8 | Downgrade | Buy → Hold | Get Alert |
| 01/30/2025 | Buy Now | 81.82% | RBC Capital | Douglas Miehm41% | $11 → $10 | Maintains | Sector Perform | Get Alert |
| 11/01/2024 | Buy Now | 100% | RBC Capital | Douglas Miehm48% | $10 → $11 | Maintains | Sector Perform | Get Alert |
| 08/02/2024 | Buy Now | 54.55% | RBC Capital | Douglas Miehm48% | $10 → $8.5 | Maintains | Sector Perform | Get Alert |
| 08/02/2024 | Buy Now | -45.45% | Piper Sandler | David Amsellem46% | $9 → $3 | Downgrade | Neutral → Underweight | Get Alert |
| 07/25/2024 | Buy Now | 27.27% | Truist Securities | Gregory Fraser38% | $8 → $7 | Maintains | Hold | Get Alert |
| 07/10/2024 | Buy Now | 45.45% | Raymond James | Michael Freeman1% | → $8 | Initiates | → Market Perform | Get Alert |
| 04/23/2024 | Buy Now | 100% | RBC Capital | Douglas Miehm48% | $12 → $11 | Maintains | Sector Perform | Get Alert |
| 04/12/2024 | Buy Now | 118.18% | RBC Capital | Douglas Miehm48% | $12 → $12 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 04/05/2024 | Buy Now | 118.18% | RBC Capital | Douglas Miehm48% | $9 → $12 | Maintains | Sector Perform | Get Alert |
| 02/23/2024 | Buy Now | 63.64% | RBC Capital | Douglas Miehm48% | $8 → $9 | Maintains | Sector Perform | Get Alert |
| 09/20/2023 | Buy Now | 190.91% | Jefferies | David Steinberg67% | $9 → $16 | Upgrade | Hold → Buy | Get Alert |
| 06/16/2023 | Buy Now | — | TD Cowen | Ken Cacciatore27% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/22/2023 | Buy Now | 72.73% | Jefferies | David Steinberg67% | $7 → $9.5 | Maintains | Buy | Get Alert |
| 05/05/2023 | Buy Now | 45.45% | RBC Capital | Douglas Miehm48% | $9 → $8 | Maintains | Sector Perform | Get Alert |
| 09/09/2022 | Buy Now | 9.09% | Piper Sandler | David Amsellem46% | $7 → $6 | Maintains | Neutral | Get Alert |
| 09/01/2022 | Buy Now | 45.45% | RBC Capital | Douglas Miehm48% | $4.5 → $8 | Maintains | Sector Perform | Get Alert |
| 08/10/2022 | Buy Now | 45.45% | BMO Capital | Gary Nachman57% | $15 → $8 | Maintains | Market Perform | Get Alert |
| 08/10/2022 | Buy Now | -18.18% | RBC Capital | Douglas Miehm48% | $5 → $4.5 | Maintains | Sector Perform | Get Alert |
| 07/29/2022 | Buy Now | -9.09% | RBC Capital | Douglas Miehm48% | $12 → $5 | Downgrade | Outperform → Sector Perform | Get Alert |
| 07/29/2022 | Buy Now | — | JP Morgan | Chris Schott60% | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/29/2022 | Buy Now | — | Truist Securities | Gregory Fraser38% | — | Downgrade | Buy → Hold | Get Alert |
| 07/26/2022 | Buy Now | 118.18% | RBC Capital | Douglas Miehm48% | $17 → $12 | Maintains | Outperform | Get Alert |
| 06/13/2022 | Buy Now | 118.18% | JP Morgan | Chris Schott60% | → $12 | Reinstates | → Overweight | Get Alert |
| 05/13/2022 | Buy Now | 209.09% | RBC Capital | Douglas Miehm48% | $21 → $17 | Maintains | Outperform | Get Alert |
| 05/09/2022 | Buy Now | 281.82% | RBC Capital | Douglas Miehm48% | $32 → $21 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Bausch Health Companies (BHC) stock?
The latest price target for Bausch Health Companies (NYSE:BHC) was reported by Jefferies on February 6, 2025. The analyst firm set a price target for $8.00 expecting BHC to rise to within 12 months (a possible 45.45% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bausch Health Companies (BHC)?
The latest analyst rating for Bausch Health Companies (NYSE:BHC) was provided by Jefferies, and Bausch Health Companies downgraded their hold rating.
When was the last upgrade for Bausch Health Companies (BHC)?
The last upgrade for Bausch Health Companies Inc happened on September 20, 2023 when Jefferies raised their price target to $16. Jefferies previously had a hold for Bausch Health Companies Inc.
When was the last downgrade for Bausch Health Companies (BHC)?
The last downgrade for Bausch Health Companies Inc happened on February 6, 2025 when Jefferies changed their price target from $12 to $8 for Bausch Health Companies Inc.
When is the next analyst rating going to be posted or updated for Bausch Health Companies (BHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bausch Health Companies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bausch Health Companies was filed on February 6, 2025 so you should expect the next rating to be made available sometime around February 6, 2026.
Is the Analyst Rating Bausch Health Companies (BHC) correct?
While ratings are subjective and will change, the latest Bausch Health Companies (BHC) rating was a downgraded with a price target of $12.00 to $8.00. The current price Bausch Health Companies (BHC) is trading at is $5.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.